ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...

The United States Cardiovascular Devices Market is estimated at around USD 22.08 billion in 2025 and is projected to reach approximately USD 41.29 billion by 2032, reflecting strong market growth ...

New evidence on cardiovascular implantable electronic devices (CIED) lead management and the burgeoning development of new ...

Over the last weekend, Chicago played host to the 2026 edition of the Heart Rhythm Society's annual conference (HRS 2026).

Less than a year after debuting its Wirion embolic protection system, Cardiovascular Systems is recalling all of the devices manufactured and distributed between January and November 2021. The Wirion ...

Boston Scientific reported $5.065 billion in net sales for the third quarter of 2025, driven largely by demand for cardiovascular devices. The company’s cardiovascular segment grew 22.4% year over ...

A case study in aligning revenue capture with the patient journey Continuous remote monitoring of cardiac implantable electronic devices has become a standard for cardiac care. Yet, in many cardiac ...

Global cardiac surgery device market will grow from $21.1B in 2025 to $30.8B by 2032, driven by advances in imaging, transcatheter valves, and wider diagnosis ...

Key Companies in the Peripheral Vascular Devices Market: Medtronic, Boston Scientific Corporation, B. Braun SE, Braile Biomedica, JOTEC GmbH, Edwards Life Sciences ...

Medical devices are true marvels of human ingenuity. They save lives and improve quality of life in countless ways. But what happens when the materials used to make them can't keep up? In vascular ...